Theramir’s proprietary technologies are based on microRNAs (miRNAs), a class of small non-coding RNAs that can regulate multiple genes and pathways associated with cancer growth and metastasis. The company has developed a panel of miRNAs, both biological and synthetic, which can affect the function and disrupt expression of an expanding list of oncoproteins that are dysregulated in most cancer types. Thus, our technologies can be applied to the development of novel targeted therapeutics that may potentially transform the precision oncology field by creating new knowledge on the pathology of the disease and by enabling the customization and personalization of cancer treatment.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Limassol, Cy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.theramir.com
- HQ
- Limassol
- Competitors
- CyRIC | Cyprus Research & Innovation Center Ltd, German Medical Institute, Remedica, Embio Diagnostics Ltd, Bank of Cyprus Oncology Centre, Medicover Genetics, Ίδρυμα Έρευνας και Καινοτομίας/Research and Innovation Foundation, biobank.cy Center of Excellence in Biobanking and Biomedical Research, Promed Bioscience, RSL Revolutionary Labs Ltd.
Theramir Ltd Questions
Theramir Ltd's website is http://www.theramir.com
Theramir Ltd's LinkedIn profile is https://cy.linkedin.com/company/theramir-ltd
Theramir Ltd has
9 employees.
View email and phone details for 9
employees at Theramir Ltd.
Theramir Ltd's industry is
Biotechnology Research
Theramir Ltd's top competitors are
Cyric | Cyprus Research & Innovation Center Ltd,
German Medical Institute,
Remedica,
Embio Diagnostics Ltd,
Bank Of Cyprus Oncology Centre,
Medicover Genetics,
Ίδρυμα Έρευνας Και Καινοτομίας/research And Innovation Foundation,
Biobank.cy Center Of Excellence In Biobanking And Biomedical Research,
Promed Bioscience,
Rsl Revolutionary Labs Ltd.
Theramir Ltd's categories are Biotechnology Research
Theramir Ltd's founding year is 2016
